Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis.

about

Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis.

Item

http://www.wikidata.org/entity/Q48226060

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Chemically Defined Antibody- a ...... tions: A Comparative Analysis.

@en

Chemically Defined Antibody- a ...... tions: A Comparative Analysis.

@nl

type

Item

label

Chemically Defined Antibody- a ...... tions: A Comparative Analysis.

@en

Chemically Defined Antibody- a ...... tions: A Comparative Analysis.

@nl

prefLabel

Chemically Defined Antibody- a ...... tions: A Comparative Analysis.

@en

Chemically Defined Antibody- a ...... tions: A Comparative Analysis.

@nl

P1476

Chemically Defined Antibody- a ...... ations: A Comparative Analysis

@en

P2093

Dario Neri

http://www.w3.org/2001/XMLSchema#string

Fontaine Widmayer

http://www.w3.org/2001/XMLSchema#string

P2860

Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation

Targeting cancer micrometastases with monoclonal antibodies: a binding-site barrier.

Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9.

Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients.

Making antibodies by phage display technology.

Carbonic anhydrases: current state of the art, therapeutic applications and future prospects.

Small targeted cytotoxics: current state and promises from DNA-encoded chemical libraries.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors.

Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturation.

P304

1617-1621

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JACS.7B13361

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

140

http://www.w3.org/2001/XMLSchema#string

P50

Alberto Dal Corso

Samuele Cazzamalli

P577

2018-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29342352

http://www.w3.org/2001/XMLSchema#string

P932

5844464

http://www.w3.org/2001/XMLSchema#string